Oncorus, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Oncorus, Inc. (ONCR), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are ONCR insiders buying or selling?
Oncorus, Inc. insiders reported 12 open-market buys ($35.6M) and 8 sells ($1.3M) across 20 Form 4 filings — a net buying position of $34.3M.
Source: SEC EDGAR Form 4
Key Statistics (as of Dec 31, 2022)
Insider sentiment
Net buyingNet insider flow of $34.3M in net buying.
Recent ONCR insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 31, 2022 | Flynn James E | Other, 10% Owner | Sale | 336.2K | $0.26 | $88.3K |
| Dec 27, 2022 | Flynn James E | Other, 10% Owner | Sale | 73.4K | $0.27 | $19.9K |
| Dec 22, 2022 | Flynn James E | Other, 10% Owner | Sale | 128.3K | $0.29 | $37.6K |
| Dec 15, 2022 | Flynn James E | Other, 10% Owner | Sale | 13.8K | $0.39 | $5.3K |
| May 25, 2022 | Rick Wanstall | CFO and Treasurer | Purchase | 3.8K | $1.20 | $4.5K |
| May 24, 2022 | Rick Wanstall | CFO and Treasurer | Purchase | 1.6K | $1.20 | $1.9K |
| May 19, 2022 | Rick Wanstall | CFO and Treasurer | Purchase | 5.0K | $1.29 | $6.5K |
| May 16, 2022 | Rick Wanstall | CFO and Treasurer | Purchase | 38.6K | $1.14 | $44.0K |
| Nov 17, 2021 | Stephen Harbin | COO and Chief of Staff | Purchase | 30.0K | $5.79 | $173.7K |
| Jun 3, 2021 | Christophe Queva | CSO and SVP, Research | Sale | 23.6K | $16.68 | $392.8K |
| May 4, 2021 | Christophe Queva | CSO and SVP, Research | Sale | 23.6K | $15.97 | $376.1K |
| Apr 28, 2021 | Christophe Queva | CSO and SVP, Research | Sale | 18.3K | $15.22 | $277.8K |
| Apr 8, 2021 | Christophe Queva | CSO and SVP, Research | Sale | 5.3K | $15.01 | $79.6K |
| Feb 18, 2021 | Flynn James E | Director, 10% Owner | Purchase | 300.0K | $19.00 | $5.7M |
| Oct 8, 2020 | MPM SunStates Fund, L.P. | 10% Owner | Purchase | 173.8K | $15.00 | $2.6M |
| Oct 8, 2020 | MPM BioVentures 2014, L.P. | 10% Owner | Purchase | 173.8K | $15.00 | $2.6M |
| Oct 8, 2020 | Ansbert Gadicke | 10% Owner | Purchase | 325.0K | $15.00 | $4.9M |
| Oct 8, 2020 | Luke Evnin | Director, 10% Owner | Purchase | 151.2K | $15.00 | $2.3M |
| Oct 8, 2020 | UBS Oncology Impact Fund L.P. | 10% Owner | Purchase | 151.2K | $15.00 | $2.3M |
| Oct 8, 2020 | James E Flynn | Director, 10% Owner | Purchase | 1.0M | $15.00 | $15.0M |
Showing the 20 most recent of 20 Form 4 filings for Oncorus, Inc..
Most active ONCR insiders
- Flynn James E6 filings
- Christophe Queva4 filings
- Rick Wanstall4 filings
- Ansbert Gadicke1 filing
- Luke Evnin1 filing
Ask anything about ONCR insider activity
Use Trabud's AI agent to query Oncorus, Inc.'s Form 4 history in plain English — "Show me ONCR CEO purchases this year" or compare it against any other ticker.
Open the AI agentONCR insider trading FAQ
Are Oncorus, Inc. insiders buying or selling?
Across 20 SEC Form 4 filings, Oncorus, Inc. (ONCR) insiders reported 12 open-market purchases totaling $35.6M and 8 sales totaling $1.3M. That is a net buying position of $34.3M.
How many insiders trade ONCR stock?
9 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Oncorus, Inc.. The most recent filing was accepted on Dec 31, 2022.
Where does Trabud get ONCR insider trading data?
All ONCR insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.